Mifepristone has shown potential to treat a striking range of diseases and conditions, some life-threatening: fibroids, breast cancer, depression, endometriosis, Gulf War illness and maybe even other autoimmune diseases, such as chronic fatigue syndrome and multiple sclerosis. Research also suggests that mifepristone may help prevent some forms of breast cancer and can serve as an effective weekly contraceptive without the side effects of hormonal birth control.
Yet despite the drug’s promise, its development has been repeatedly stymied by abortion opponents who fear wider availability would weaken their attempts to suppress abortion access.
The result? Women are left in needless pain and subject to invasive and unnecessary surgical procedures like hysterectomies.
Get a year of Ms. for just $20—a 43 percent discount off our usual price—when you join today!
Here’s what else you’ll find in the Winter issue:
- On surviving Epstein. Michele Goodwin spoke with Jess Michaels about meeting Jeffrey Epstein, the manipulative way he recruited and trafficked young women, her experience as a victim-turned-advocate, and what she wants the public to know about sexual violence.
- The “Women’s Strike” turns 50. Ms. was in the crowd this past October when Iceland’s women demonstrated yet again in downtown Reykjavík to demand continued progress on gender equality. “We are the best in the world in many ways,” one woman told Ms. “But that’s not enough for us.”
- Out of work and out of options. Black women—who historically found more job security, as well as upward mobility, in federal employment—are now seeing those federal jobs slip away in record numbers.
When you become a member of Ms., you get the magazine in print or on our app, or both—and you’re the first to get information alerts and event invitations from our team. When you become a member, you’re supporting independent, feminist media—and becoming part of a global community of feminists who care about the issues that matter to you.
Join today to get our newest issue delivered straight to your mailbox—and fuel another year of our reporting, rebelling and truth-telling.
Great Job Ms. Editors & the Team @ Ms. Magazine Source link for sharing this story.
